3121
 
   
   
 
    Company Overview
    Board
    Corporate Governance  
    Financial Reports
    Presentations
    Company Announcements
     AIM
    Shareholder Information

 -

Share Price Information

 -

Investor Downloads

 -

Investor Contacts

 
    Sign up for e-updates
 
 
Board
 
 

Associate Professor Andrew Vizard (BVSc (Hons) MVPM) Chairman & Independent Director

With a background in research and agricultural consultancy, Professor Vizard is the senior consultant with, and former Director of the Mackinnon Project at the University of Melbourne. This enterprise is recognised as a world leader in delivering practical advice to farmer and agribusiness on a wide range of agricultural and economic issues. He is the author of over 50 scientific papers.

Professor Vizard is currently a non-executive Director of Ridley Corporation Ltd, Animal Health Australia Ltd and the Zoological Parks and Gardens Board of Victoria. He is also a Trustee of The Australian Wool Education Trust. No other listed directorships have been held within the past 3 year period.

Professor Vizard is a member of the Company's Audit, Compliance and Corporate Governance Committee.

     
 

Harry Rosen (BA, LLB)
Chief Executive Officer & President

Mr Rosen is an Executive Director of Phosphagenics Limited and is a non-practicing lawyer. He is one of the founders of Betatene Ltd and Denehurst Ltd, two formerly ASX listed companies which commercialised significant research and development. Betatene is the world's largest producer of natural beta carotene. After the purchase of Betatene Ltd by Henkel Corporation, Mr Rosen served as Vice-President, Corporate Development. As a Vice-President of Henkel Corporation, he worked for a number of years in the US in the nutrition and health care industries.

Mr Rosen has consulted to many technology companies assisting them with the commercialisation of new technologies. He has had significant experience in the areas of seed capital raising, stock exchange listings, taxation and corporate law. Mr Rosen graduated from the Australian National University (B.A.- Psychology) in 1970 and Melbourne University (LLB) in 1973.

     
 
 

Dr Esra Ogru (BSc (Hons) PhD)
Executive Vice President 

Dr Ogru is an Executive Director of Phosphagenics and is responsible for the coordination and management of the pre-clinical, clinical and development research in Australia and internationally. She achieves this through leadership of a team of experienced pharmaceutical scientists and chemists and strategic collaborations.

In this role, Dr Ogru has developed commercial opportunities for both the Company’s nutraceutical division and pharmaceutical technologies, such as transdermal drug delivery and drug enhancement platforms for cancer, heart disease and chronic pain management.

Dr Ogru has many years experience in both the academic and commercial aspects of the industry. Prior to joining Phosphagenics in 2001, Dr Ogru carried out significant research on obesity and diabetes. Additionally she has considerable experience in the management and coordination of pre-clinical and clinical development of pharmaceutical products.

Dr Ogru has numerous publications in peer-reviewed journals.


 

   
 

Professor John Mills (BS(Hons), MD, FACP, FRACP, ARCPA)
Independent Director

Professor Mills has a long and distinguished career in medical research, clinical medicine and biomedical business. In addition to his position as a non-executive director of Phosphagenics, he is the Executive Chairman of Swedish company, Cavidi AB, an Executive Director of TissuPath Pty Ltd, a non-executive director of GBS Venture Partners Pty Ltd (Australia's largest biotechnology venture capital company), and a non-executive director of the Prostate Cancer Foundation of Australia and Chair of the PCFA Research Committee. He has previously been a non-executive director and Chairman of AMRAD Corporation Ltd and Managing Director of Narhex Life Sciences Ltd (ASX: NLS).

He holds professorial appointments at Monash University and RMIT, and is a consulting physician at the Alfred and Austin hospitals in Melbourne.

He has published over 200 scientific articles and has served as a consultant to industry and governments, the World Health Organisation and the United Nations.

Professor Mills is a member of the Company’s Audit, Compliance and Corporate Governance Committee.

     
 

Jonathan Addison  (BEc (Tas), ASIC, FTA (Snr)) Independent Director

Mr Addison has over 30 years in the investment management industry, including wide experience in superannuation. Currently he is the Investment Manager of the Meat Industry Employee Superannuation Fund ("MIESF") whom he joined in June 1999 and where he is responsible for the overall management of MIESF. MIESF is a self-administered industry superannuation fund established in 1981 which operates nationally.

Prior to his appointment to MIESF, Mr Addison was a Director and Asset Consultant within the Corporate Finance section of PricewaterhouseCoopers and in this role was responsible for establishing an investment consulting practice with clients ranging from superannuation funds to insurance funds and funds managers. Prior to that, he was Manager Investment Consultant at Sedgwick Noble Lowndes.

Mr Addison also holds non-executive directorships with African Enterprise Limited, Australian Enterprises New Zealand Limited, Hawksbridge Limited, Global Masters Fund Limited and TPCG. No other listed company directorships have been held during the last 3 year period.

Mr Addisson is the Chairman of the Company’s Audit, Compliance and Corporate Governance Committee.

     
 

Michael David Preston (MA, FCA)
Non-Executive Director

Mr Preston is a principal partner and founder of Capidem LLP, an FSA-regulated corporate finance and turnaround firm based in London. Capidem specialises in media, technology and life sciences and in the turnaround of buisnesses in difficulty.

Mr Preston was previously a founder of Sterling Publishing Group PLC, a business publishing company that was publicly listed in London in 1985. He was also a founder of the Broad Street Group PLC, a marketing services company that was publicly listed in London in 1986 and eventually acquired by the French Group BDDP.

Mr Preston has extensive experience as a financial and strategic adviser to many growing companies in the UK and U.S. He is a Fellow of the Institute of Chartered Accountants in England and Wales and shares his time between New York and London.

 
  Home About Us Pharmaceuticals Nutraceuticals Investors News Contact Us Privacy & Disclaimer Site Map
 

Copyright 2005 Phosphagenics Limited

Web Site Design & Business Hosting by Simple I.D.Simple I.D. website design & business hosting Melbourne